--:--:--LOCAL ·--:--UTC
    US EQUITIESLAST CLOSE
    AAPL$333.69+1.02%
    MSFT$517.53+0.92%
    GOOGL$343.50+1.56%
    AMZN$251.52+1.33%
    NVDA$233.95+1.34%
    META$728.08+0.30%
    TSLA$370.59+4.65%
    NFLX$67.06-1.16%
    BRK.B$502.65+0.43%
    AVGO$355.14+3.35%
    DIS$102.19+0.85%
    SBUX$94.71-0.18%
    MCD$231.89+0.03%
    NKE$33.87-3.64%
    COST$920.65+0.62%
    WMT$104.26+0.00%
    HD$282.85+0.14%
    KO$85.65-0.52%
    PG$144.91+0.67%
    ORCL$142.30+3.06%
    CRM$234.69-0.84%
    ADBE$237.69-1.49%
    AMD$633.91+2.95%
    INTC$119.33-0.56%
    QCOM$184.87+1.53%
    CSCO$112.20+3.16%
    IBM$222.64-1.32%
    UBER$68.11+0.34%
    ABNB$162.43+1.22%
    SHOP$151.39+1.54%
    PYPL$52.80-0.49%
    COIN$183.00-3.32%
    PLTR$188.75-0.68%
    HOOD$112.74+1.43%
    JPM$332.38-0.24%
    V$360.66+0.23%
    MA$552.26+0.41%
    BAC$53.75+0.04%
    GS$902.56+0.66%
    LLY$1142.85-0.61%
    UNH$371.90+1.83%
    JNJ$256.03-1.02%
    PFE$27.80-1.14%
    XOM$164.01+0.12%
    BA$193.56+0.67%
    BABA$105.85-1.49%
    TSM$472.78+2.96%
    US EQUITIESLAST CLOSE
    AAPL$333.69+1.02%
    MSFT$517.53+0.92%
    GOOGL$343.50+1.56%
    AMZN$251.52+1.33%
    NVDA$233.95+1.34%
    META$728.08+0.30%
    TSLA$370.59+4.65%
    NFLX$67.06-1.16%
    BRK.B$502.65+0.43%
    AVGO$355.14+3.35%
    DIS$102.19+0.85%
    SBUX$94.71-0.18%
    MCD$231.89+0.03%
    NKE$33.87-3.64%
    COST$920.65+0.62%
    WMT$104.26+0.00%
    HD$282.85+0.14%
    KO$85.65-0.52%
    PG$144.91+0.67%
    ORCL$142.30+3.06%
    CRM$234.69-0.84%
    ADBE$237.69-1.49%
    AMD$633.91+2.95%
    INTC$119.33-0.56%
    QCOM$184.87+1.53%
    CSCO$112.20+3.16%
    IBM$222.64-1.32%
    UBER$68.11+0.34%
    ABNB$162.43+1.22%
    SHOP$151.39+1.54%
    PYPL$52.80-0.49%
    COIN$183.00-3.32%
    PLTR$188.75-0.68%
    HOOD$112.74+1.43%
    JPM$332.38-0.24%
    V$360.66+0.23%
    MA$552.26+0.41%
    BAC$53.75+0.04%
    GS$902.56+0.66%
    LLY$1142.85-0.61%
    UNH$371.90+1.83%
    JNJ$256.03-1.02%
    PFE$27.80-1.14%
    XOM$164.01+0.12%
    BA$193.56+0.67%
    BABA$105.85-1.49%
    TSM$472.78+2.96%
    Plug stock market data into your AI agent — one command: Get your free API key →
    LoginGet API Key
    Company data coverage · NYSE

    ABBV — AbbVie

    Data coverage, completeness and provenance for AbbVie in the Stock Market API — Health Care · Drug Manufacturers - General.

    NYSE USA S&P 500
    Core-field completeness
    100.0%
    Statement periods
    FY2021–FY2025
    Filings archived
    0
    Price captured
    2026-10-03 23:01 UTC

    Profile

    AbbVie Inc., a research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing, and sale of medicines and therapies worldwide. The company offers Skyrizi to treat autoimmune diseases; Rinvoq to treat inflammatory diseases; Imbruvica for the treatment of adult patients with blood cancers; Venclexta to treat blood cancers; Elahere to treat various cancer; and Epkinly to treat lymphoma; and Emrelis for the treatment of lung cancer. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; botox Cosmetic for the treatment of glabellar lines, crow's feet, forehead lines, and platysma bands; Juvederm Collection to treat volume loss in the temples, undereye, cheeks, chin, lips and lower face; Vraylar to treat schizophrenia, bipolar disorder, and depressive disorder; Duodopa to treat Parkinson's disease; Ubrelvy to treat migraine; Qulipta for episodic and chronic migraine; and Vyalev for the treatment of motor fluctuations, as well as Botox Therapeutic to treat chronic migraine, overactive bladder, spasticity, cervical dystonia, and other conditions. In addition, the company offers Ozurdex for visual impairment; Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension; and other eye care products, including Refresh/Optive, Xen, Durysta, and Restasis. Further, it provides Mavyret to treat chronic hepatitis C virus genotype 1-6 infection; Creon, a pancreatic enzyme therapy; and Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.

    Employees: 57,000 · Website: https://www.abbvie.com · Profile fields populated: 75%

    Data completeness by statement

    Share of stored fields populated in the anchor reporting period (FY2025), primary source sec_edgar. Full per-field breakdown: GET /api/v1/companies/ABBV/financials.

    Income statement9/10 fields (90.0%)
    Balance sheet14/14 fields (100.0%)
    Cash flow6/6 fields (100.0%)
    Per-share3/4 fields (75.0%)

    Financial statement coverage (USD)

    Stored values for the most recent fiscal-year periods, with per-period field counts and the primary source each period came from. Values are shown at reported scale without interpretation.

    PeriodPeriod end RevenueNet incomeTotal assetsTotal equity Fields populatedSource
    FY2025 2025-12-31 30 sec_edgar
    FY2024 2024-12-31 30 sec_edgar
    FY2023 2023-12-31 30 sec_edgar
    FY2022 2022-12-31 30 sec_edgar
    FY2021 2021-12-31 30 sec_edgar

    Get ABBV data via the API

    Every number on this page is one API call away. Free API keys — no card required.

    Company profile

    Name, sector, industry, HQ, employees, market cap, source-tagged.

    GET /api/v1/companies/ABBV

    Financial statements

    Multi-year statements with per-field source tags and completeness.

    GET /api/v1/companies/ABBV/financials

    Computed ratios

    P/E, P/B, ROE, ROA, margins, EPS, debt/equity — formulas documented.

    GET /api/v1/companies/ABBV/metrics/summary

    Filings archive

    Report PDFs with LLM-ready markdown conversions where available.

    GET /api/v1/companies/ABBV/filings

    News & announcements

    Dated press releases and announcements with source links.

    GET /api/v1/companies/ABBV/news

    Quick start

    Create a free key, then:

    curl -H "X-API-Key: KEY" https://stockmarketapi.ai/api/v1/companies/ABBV

    Query ABBV programmatically

    Free tier — instant API key. Built for AI agents.

    Other NYSE · Health Care companies covered

    Frequently Asked Questions

    What data does the API provide for ABBV?
    Company profile, financial statements, computed ratios, price data, filings and news for ABBV, via REST endpoints under /api/v1/companies/ABBV. Every financial field carries a source tag for provenance.
    How complete is ABBV's financial data?
    The anchor reporting period (FY2025) has 100.0% of the 17 core statement fields populated. Primary source: sec_edgar.
    What reporting periods are covered for ABBV?
    5 fiscal-year periods are stored (FY2021–FY2025), with per-period field counts and source tags available via /api/v1/companies/ABBV/financials.
    Where does ABBV's data come from?
    Primary source for the latest statements: sec_edgar. The API records a source tag on every field and exposes them via /api/v1/companies/ABBV/financials, so each value is traceable.